Skip to content
L8L8L8

Drawing based on the label description. No photo yet.

“20 mg pantoprazole, light brown to brown, round, biconvex, delayed-release tablets imprinted with 'L8' on one side and plain on other side”

L8 pill

Pill with imprint L8 is brown, round, 6 mm and has been identified as Pantoprazole Sodium Delayed-Release 20 mg. It is used for heartburn and acid reflux. It is supplied by Lifestar Pharma LLC.

Pantoprazole Sodium Delayed-Release 20 mg

Imprint
L8
Strength
20 mg
Used for
Heartburn and acid reflux
Color
Brown
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet
Manufacturer
Lifestar Pharma LLC
NDC
70756-018, 70756-018-90, 70756-018-51

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Pantoprazole Sodium Delayed-Release pills and guides

What is Pantoprazole Sodium Delayed-Release used for?

Pantoprazole Sodium Delayed-Release is used for heartburn and acid reflux.

Official uses from the US prescribing label

Pantoprazole sodium delayed-release tablets are indicated for:

Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD)

Pantoprazole sodium is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (EE). For those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole sodium delayed-release tablets may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been established.

Maintenance of Healing of Erosive Esophagitis

Pantoprazole sodium delayed-release tablets are indicated for maintenance of healing of EE and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD. Controlled studies did not extend beyond 12 months.

Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome

Pantoprazole sodium is indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison (ZE) Syndrome.

From the FDA-approved label on DailyMed (published Sep 15, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows L8 and the other side is plain.
  • It is brown, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Pantoprazole Sodium

Inactive: Ammonia, Butyl Alcohol, Calcium Stearate, Crospovidone, Ferric Oxide Red, Ferrosoferric Oxide, Hypromellose 2910 (3 Mpa.s), Isopropyl Alcohol, Mannitol, Methacrylic Acid and Ethyl Acrylate Copolymer, Polyethylene Glycol 400, Propylene Glycol, Shellac, Silicon Dioxide, Sodium Carbonate, Sucrose, Talc, Triethyl Citrate

Other pills with imprint L 8

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Pantoprazole Sodium Delayed-Release pills